Characterization of protease expression in human prostate cancer cell lines Journal Article


Authors: Weiss, R. E.; Fair, W. R.; Cordon-Cardo, C.
Article Title: Characterization of protease expression in human prostate cancer cell lines
Abstract: To better understand the biochemical mechanisms necessary for prostate cancer invasion and metastases, we studied the expression and interaction of proteolytic enzymes cathepsin D, cathepsin B, urokinase and collagenase IV in human prostate cell lines LNCAP (hormone sensitive) and DU145 (hormone refractory). Cellular fractionation and immunoblotting revealed that both cell lines expressed similar amounts of the 34 kD form of cathepsin D, 72 kD form of collagenase IV and the 55 kD form of urokinase. However, DU145 expressed an increased amount of the 28 kD form of cathepsin B. When E64, a cysteine protease inhibitor was added, a decreased amount of the active cathepsin D was expressed. Furthermore, when cathepsin L was added to concentrated plasma membrane homogenates, urokinase was processed to its active form at 33 kD. E64 inhibited the ability of both cell lines to degrade fibronectin. An in vitro Boyden chamber demonstrated that DU145 was more motile than LNCAP and that preincubation with E64 could decrease motility of both cell lines. We suggest that cathepsin B may promote tumor invasion not only by proteolysis of basement membrane components, but also by activating other proteases.
Keywords: controlled study; unclassified drug; human cell; prostate cancer; cancer invasion; tumor cell line; cathepsin b; cathepsin d; prostate carcinoma; urokinase; proteases; hormone dependence; human; priority journal; article; collagenase iv
Journal Title: International Journal of Oncology
Volume: 5
Issue: 4
ISSN: 1019-6439
Publisher: Spandidos Publications  
Date Published: 1994-10-01
Start Page: 973
End Page: 978
Language: English
PROVIDER: scopus
PUBMED: 21559669
DOI: 10.3892/ijo.5.4.973
DOI/URL:
Notes: Export Date: 14 January 2019 -- Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William R Fair
    342 Fair